Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MLND

Millendo Therapeutics (MLND) Stock Price, News & Analysis

Millendo Therapeutics logo

About Millendo Therapeutics Stock (NASDAQ:MLND)

Advanced Chart

Key Stats

Today's Range
$6.61
$7.25
50-Day Range
$3.06
$5.84
52-Week Range
$0.92
$16.95
Volume
34,504 shs
Average Volume
1.52 million shs
Market Capitalization
$130.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MLND Stock News Headlines

Trump Orders 'National Digital Asset Stockpile'
Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Expert Ratings for Decibel Therapeutics
See More Headlines

MLND Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Millendo Therapeutics investors own include Elbit Systems (ESLT), UnitedHealth Group (UNH), AbbVie (ABBV), American Water Works (AWK), Bright Health Group (BHG), Black Hills (BKH) and Blackrock Municipal 2030 Target Term Trust (BTT).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MLND
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-36,410,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.78 per share
Price / Book
3.85

Miscellaneous

Free Float
N/A
Market Cap
$130.44 million
Optionable
Not Optionable
Beta
0.48
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:MLND) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners